These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 31806041)

  • 21. Brain tumour diagnostics using a DNA methylation-based classifier as a diagnostic support tool.
    Priesterbach-Ackley LP; Boldt HB; Petersen JK; Bervoets N; Scheie D; Ulhøi BP; Gardberg M; Brännström T; Torp SH; Aronica E; Küsters B; den Dunnen WFA; de Vos FYFL; Wesseling P; de Leng WWJ; Kristensen BW
    Neuropathol Appl Neurobiol; 2020 Aug; 46(5):478-492. PubMed ID: 32072658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating Genomics Into Neuro-Oncology Clinical Trials and Practice.
    Galanis E; Nassiri F; Coy S; Nejad R; Zadeh G; Santagata S
    Am Soc Clin Oncol Educ Book; 2018 May; 38():148-157. PubMed ID: 30231374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.
    Fukuoka K; Kanemura Y; Shofuda T; Fukushima S; Yamashita S; Narushima D; Kato M; Honda-Kitahara M; Ichikawa H; Kohno T; Sasaki A; Hirato J; Hirose T; Komori T; Satomi K; Yoshida A; Yamasaki K; Nakano Y; Takada A; Nakamura T; Takami H; Matsushita Y; Suzuki T; Nakamura H; Makino K; Sonoda Y; Saito R; Tominaga T; Matsusaka Y; Kobayashi K; Nagane M; Furuta T; Nakada M; Narita Y; Hirose Y; Ohba S; Wada A; Shimizu K; Kurozumi K; Date I; Fukai J; Miyairi Y; Kagawa N; Kawamura A; Yoshida M; Nishida N; Wataya T; Yamaoka M; Tsuyuguchi N; Uda T; Takahashi M; Nakano Y; Akai T; Izumoto S; Nonaka M; Yoshifuji K; Kodama Y; Mano M; Ozawa T; Ramaswamy V; Taylor MD; Ushijima T; Shibui S; Yamasaki M; Arai H; Sakamoto H; Nishikawa R; Ichimura K;
    Acta Neuropathol Commun; 2018 Dec; 6(1):134. PubMed ID: 30514397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study.
    White CL; Kinross KM; Moore MK; Rasouli E; Strong R; Jones JM; Cain JE; Sturm D; Sahm F; Jones DTW; Pfister SM; Robertson T; D'Arcy C; Rodriguez ML; Dyke JM; Junckerstorff R; Bhuva DD; Davis MJ; Wood P; Hassall T; Ziegler DS; Kellie S; McCowage G; Alvaro F; Kirby M; Heath JA; Tsui K; Dodgshun A; Eisenstat DD; Khuong-Quang DA; Wall M; Algar EM; Gottardo NG; Hansford JR
    J Mol Diagn; 2023 Oct; 25(10):709-728. PubMed ID: 37517472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decoding the DNA methylome of central nervous system tumors: An emerging modality for integrated diagnosis.
    Satomi K; Ichimura K; Shibahara J
    Pathol Int; 2024 Feb; 74(2):51-67. PubMed ID: 38224248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.
    Onizuka H; Masui K; Komori T
    Int J Clin Oncol; 2020 Jun; 25(6):997-1003. PubMed ID: 32468200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entities.
    Korshunov A; Jakobiec FA; Eberhart CG; Hovestadt V; Capper D; Jones DT; Sturm D; Stagner AM; Edward DP; Eagle RC; Proia AD; Koch A; Ryzhova M; Ektova A; Schüller U; Zheludkova O; Lichter P; von Deimling A; Pfister SM; Kool M
    Neuropathology; 2015 Dec; 35(6):538-44. PubMed ID: 26183384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation provides diagnostic value for meningioma recurrence in clinical practice.
    Shen E; Leclair NK; Herlth K; Soucy M; Renzette N; Zhuo X; Kelly K; Omerza G; Onyiuke H; McNeill I; Wolansky L; Becker K; Li L; Wu Q; Bulsara KR
    Acta Neurochir (Wien); 2023 May; 165(5):1323-1331. PubMed ID: 36920663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copy number assessment in the genomic analysis of CNS neoplasia: An evidence-based review from the cancer genomics consortium (CGC) working group on primary CNS tumors.
    Neill SG; Hauenstein J; Li MM; Liu YJ; Luo M; Saxe DF; Ligon AH
    Cancer Genet; 2020 May; 243():19-47. PubMed ID: 32203924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards an integrated morphological and molecular WHO diagnosis of central nervous system tumors: a paradigm shift.
    Rushing EJ; Wesseling P
    Curr Opin Neurol; 2015 Dec; 28(6):628-32. PubMed ID: 26402407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features.
    Deng MY; Sill M; Chiang J; Schittenhelm J; Ebinger M; Schuhmann MU; Monoranu CM; Milde T; Wittmann A; Hartmann C; Sommer C; Paulus W; Gärtner J; Brück W; Rüdiger T; Leipold A; Jaunmuktane Z; Brandner S; Giangaspero F; Nozza P; Mora J; Morales la Madrid A; Cruz Martinez O; Hansford JR; Pietsch T; Tietze A; Hernáiz-Driever P; Stoler I; Capper D; Korshunov A; Ellison DW; von Deimling A; Pfister SM; Sahm F; Jones DTW
    Acta Neuropathol; 2018 Aug; 136(2):239-253. PubMed ID: 29766299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microarray-Based DNA Methylation Profiling: Validation Considerations for Clinical Testing.
    Leung ML; Abdullaev Z; Santana-Santos L; Skaugen JM; Moore S; Ji J
    J Mol Diagn; 2024 Jun; 26(6):447-455. PubMed ID: 38378079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
    Keck MK; Sill M; Wittmann A; Joshi P; Stichel D; Beck P; Okonechnikow K; Sievers P; Wefers AK; Roncaroli F; Avula S; McCabe MG; Hayden JT; Wesseling P; Øra I; Nistér M; Kranendonk MEG; Tops BBJ; Zapotocky M; Zamecnik J; Vasiljevic A; Fenouil T; Meyronet D; von Hoff K; Schüller U; Loiseau H; Figarella-Branger D; Kramm CM; Sturm D; Scheie D; Rauramaa T; Pesola J; Gojo J; Haberler C; Brandner S; Jacques T; Sexton Oates A; Saffery R; Koscielniak E; Baker SJ; Yip S; Snuderl M; Ud Din N; Samuel D; Schramm K; Blattner-Johnson M; Selt F; Ecker J; Milde T; von Deimling A; Korshunov A; Perry A; Pfister SM; Sahm F; Solomon DA; Jones DTW
    Acta Neuropathol; 2023 Jan; 145(1):49-69. PubMed ID: 36437415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.
    Sturm D; Capper D; Andreiuolo F; Gessi M; Kölsche C; Reinhardt A; Sievers P; Wefers AK; Ebrahimi A; Suwala AK; Gielen GH; Sill M; Schrimpf D; Stichel D; Hovestadt V; Daenekas B; Rode A; Hamelmann S; Previti C; Jäger N; Buchhalter I; Blattner-Johnson M; Jones BC; Warmuth-Metz M; Bison B; Grund K; Sutter C; Hirsch S; Dikow N; Hasselblatt M; Schüller U; Koch A; Gerber NU; White CL; Buntine MK; Kinross K; Algar EM; Hansford JR; Gottardo NG; Schuhmann MU; Thomale UW; Hernáiz Driever P; Gnekow A; Witt O; Müller HL; Calaminus G; Fleischhack G; Kordes U; Mynarek M; Rutkowski S; Frühwald MC; Kramm CM; von Deimling A; Pietsch T; Sahm F; Pfister SM; Jones DTW
    Nat Med; 2023 Apr; 29(4):917-926. PubMed ID: 36928815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.
    Sturm D; Orr BA; Toprak UH; Hovestadt V; Jones DTW; Capper D; Sill M; Buchhalter I; Northcott PA; Leis I; Ryzhova M; Koelsche C; Pfaff E; Allen SJ; Balasubramanian G; Worst BC; Pajtler KW; Brabetz S; Johann PD; Sahm F; Reimand J; Mackay A; Carvalho DM; Remke M; Phillips JJ; Perry A; Cowdrey C; Drissi R; Fouladi M; Giangaspero F; Łastowska M; Grajkowska W; Scheurlen W; Pietsch T; Hagel C; Gojo J; Lötsch D; Berger W; Slavc I; Haberler C; Jouvet A; Holm S; Hofer S; Prinz M; Keohane C; Fried I; Mawrin C; Scheie D; Mobley BC; Schniederjan MJ; Santi M; Buccoliero AM; Dahiya S; Kramm CM; von Bueren AO; von Hoff K; Rutkowski S; Herold-Mende C; Frühwald MC; Milde T; Hasselblatt M; Wesseling P; Rößler J; Schüller U; Ebinger M; Schittenhelm J; Frank S; Grobholz R; Vajtai I; Hans V; Schneppenheim R; Zitterbart K; Collins VP; Aronica E; Varlet P; Puget S; Dufour C; Grill J; Figarella-Branger D; Wolter M; Schuhmann MU; Shalaby T; Grotzer M; van Meter T; Monoranu CM; Felsberg J; Reifenberger G; Snuderl M; Forrester LA; Koster J; Versteeg R; Volckmann R; van Sluis P; Wolf S; Mikkelsen T; Gajjar A; Aldape K; Moore AS; Taylor MD; Jones C; Jabado N; Karajannis MA; Eils R; Schlesner M; Lichter P; von Deimling A; Pfister SM; Ellison DW; Korshunov A; Kool M
    Cell; 2016 Feb; 164(5):1060-1072. PubMed ID: 26919435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultra-fast deep-learned CNS tumour classification during surgery.
    Vermeulen C; Pagès-Gallego M; Kester L; Kranendonk MEG; Wesseling P; Verburg N; de Witt Hamer P; Kooi EJ; Dankmeijer L; van der Lugt J; van Baarsen K; Hoving EW; Tops BBJ; de Ridder J
    Nature; 2023 Oct; 622(7984):842-849. PubMed ID: 37821699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14.
    Deng MY; Sill M; Sturm D; Stichel D; Witt H; Ecker J; Wittmann A; Schittenhelm J; Ebinger M; Schuhmann MU; Figarella-Branger D; Aronica E; Staszewski O; Preusser M; Haberler C; Lauten M; Schüller U; Hartmann C; Snuderl M; Dunham C; Jabado N; Wesseling P; Deckert M; Keyvani K; Gottardo N; Giangaspero F; von Hoff K; Ellison DW; Pietsch T; Herold-Mende C; Milde T; Witt O; Kool M; Korshunov A; Wick W; von Deimling A; Pfister SM; Jones DTW; Sahm F
    Neuropathol Appl Neurobiol; 2020 Aug; 46(5):422-430. PubMed ID: 31867747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas.
    Otani Y; Satomi K; Suruga Y; Ishida J; Fujii K; Ichimura K; Date I
    Brain Tumor Pathol; 2023 Apr; 40(2):56-65. PubMed ID: 37004583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.
    Galbraith K; Vasudevaraja V; Serrano J; Shen G; Tran I; Abdallat N; Wen M; Patel S; Movahed-Ezazi M; Faustin A; Spino-Keeton M; Roberts LG; Maloku E; Drexler SA; Liechty BL; Pisapia D; Krasnozhen-Ratush O; Rosenblum M; Shroff S; Boué DR; Davidson C; Mao Q; Suchi M; North P; Hopp A; Segura A; Jarzembowski JA; Parsons L; Johnson MD; Mobley B; Samore W; McGuone D; Gopal PP; Canoll PD; Horbinski C; Fullmer JM; Farooqui MS; Gokden M; Wadhwani NR; Richardson TE; Umphlett M; Tsankova NM; DeWitt JC; Sen C; Placantonakis DG; Pacione D; Wisoff JH; Teresa Hidalgo E; Harter D; William CM; Cordova C; Kurz SC; Barbaro M; Orringer DA; Karajannis MA; Sulman EP; Gardner SL; Zagzag D; Tsirigos A; Allen JC; Golfinos JG; Snuderl M
    Neurooncol Adv; 2023; 5(1):vdad076. PubMed ID: 37476329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DistSNE: Distributed computing and online visualization of DNA methylation-based central nervous system tumor classification.
    Schmid K; Sehring J; Németh A; Harter PN; Weber KJ; Vengadeswaran A; Storf H; Seidemann C; Karki K; Fischer P; Dohmen H; Selignow C; von Deimling A; Grau S; Schröder U; Plate KH; Stein M; Uhl E; Acker T; Amsel D
    Brain Pathol; 2024 May; 34(3):e13228. PubMed ID: 38012085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.